about
The endocannabinoid system as an emerging target of pharmacotherapyCannabis and psychosis: NeurobiologyEnhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout miceEffect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritabilityToward the Identification of a Specific Psychopathology of Substance Use Disorders.Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental modelsPotential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family studyMedical use of cannabis. Cannabidiol: a new light for schizophrenia?Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment.Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditionsClinical presentations of substance abuse in bipolar heroin addicts at time of treatment entryCannabis use and the mental health of young people.The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders.Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptomsChemistry, metabolism, and toxicology of cannabis: clinical implications.What are the policy implications of the evidence on cannabis and psychosis?Cannabis withdrawal in chronic cannabis users with schizophreniaSpinal cord and related injuries after attempted suicide: psychiatric diagnosis and long-term follow-up.Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.Cannabis Use and Associated Harms among Schizophrenia Patients in a Nigerian Clinical Setting: A Case-Control Study.Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.Candidate genes for cannabis use disorders: findings, challenges and directionsAnxiety and mood disorders and cannabis use.Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin.Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders.Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans.Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.Health effects of using cannabis for therapeutic purposes: a gender analysis of users' perspectives.Alcohol, Tobacco, and Prescription Drugs: The Relationship With Illicit Drugs in the Treatment of Substance Users
P2860
Q24648473-E42F577E-ACAE-41A6-ABA7-D2F73CAFAD8FQ27024404-A9600AE4-2D30-4699-AB9B-C459095D7B40Q28482464-A456C998-00C7-4EF7-813A-F28350CC6D68Q30489165-F7C21F70-134E-4876-A105-56CAFCB05108Q31095554-8E4923A4-ED0D-4BF0-90F3-CA06DD523E0BQ31149257-268FD98A-8F9F-4693-BE00-B33381AF815FQ33585794-EDD34D85-FD72-49CE-8675-7BACDBF14140Q33607241-2989A0AA-0A9E-4DC7-9963-8078B9D5DCE1Q33818659-80FCC3AD-8F06-4A0A-B35C-CECB32BB5932Q34098209-0CD3AB91-8B43-410F-8A23-6F5AC147E055Q34103173-1714BA6D-1F89-4C0A-B578-5868C7513356Q34133171-1608B7EA-A388-4669-9268-1DD6D7BDF8A2Q34308885-32CB1C0C-C357-4D72-B4C6-8B0554683585Q34586382-D3EC5F6F-461C-472E-A4AE-8A332E9636AAQ35866473-14887823-6DEB-4713-ADE7-C6370674E530Q36323446-C509EF82-9C6A-4994-BF64-95EA29C6DC69Q36395724-E3652BF8-3803-4497-BF86-9AA0E16207D9Q36410792-64147560-C30F-4432-8EAA-B10B76E2FA52Q36425951-530A7354-62AF-4102-80A0-BC6D35E6083FQ36597593-C8FE9751-6CBE-42A8-8DAB-5315465900BCQ36604757-F0DDF8BA-8CAD-4CA0-B01F-6F8B0E3888FBQ36606248-4D2D0905-3426-4BB8-B27B-0D7786398B26Q36666842-A4B980CF-7901-4169-A04E-01A0F5174AD4Q36752685-762404D0-21B9-4D4E-A067-5698CF9A20A8Q36891392-778A2DE2-0EF6-4595-961C-D94E4E9B31CCQ37147730-12A62248-648A-45BB-B70D-462BB531D4B9Q37237991-FBC2F74C-6CD7-4DD5-9679-6778689BF394Q37245382-E2E8B473-5599-436E-A7AE-C9458CF4338EQ43118934-9D4268C6-D0CF-47A5-BB75-46B971AD7DAAQ43543901-55A52DFE-A70D-4E17-AD22-5D6235D4E96DQ44174282-8BD7E7FC-DC4E-48A3-B065-1DA56F5647F9Q45326783-C45D13BD-D721-42F4-B6E8-B95115D09250Q45326918-E1CD4129-8B02-4600-9E86-8B9E491DDB5AQ46489466-1CE3C0B1-9BAD-4C41-96EF-3563F14460C9Q52297712-53D55C71-8E76-4453-93CB-8939FD22400FQ58091142-8A61C0AA-8121-4D34-B2C2-4466B59270E5
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cannabis use and psychotic disorders: an update.
@ast
Cannabis use and psychotic disorders: an update.
@en
Cannabis use and psychotic disorders: an update.
@nl
type
label
Cannabis use and psychotic disorders: an update.
@ast
Cannabis use and psychotic disorders: an update.
@en
Cannabis use and psychotic disorders: an update.
@nl
prefLabel
Cannabis use and psychotic disorders: an update.
@ast
Cannabis use and psychotic disorders: an update.
@en
Cannabis use and psychotic disorders: an update.
@nl
P50
P1476
Cannabis use and psychotic disorders: an update.
@en
P304
P356
10.1080/09595230412331324554
P407
P577
2004-12-01T00:00:00Z